[ {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#pubinfo"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#Head"
}, {
  "@graph" : [ {
    "@id" : "http://purl.obolibrary.org/obo/DOID_4989",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Disease"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#association",
    "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://purl.obolibrary.org/obo/DOID_4989"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "https://w3id.org/biolink/vocab/treats"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "https://identifiers.org/drugbank:DB00900"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "\"Coadministration with stavudine allopurinol or ribavirin is contraindicated. ( 4 VIDEX EC is contraindicated when coadministered with the following medications:   Stavudine- potential for serious and/or life-threatening events, notably pancreatitis, lactic acidosis, hepatotoxicity, and peripheral neuropathy [ see  Warnings and Precautions 5.1 5.2 5.3 5.5   Allopurinol- systemic exposures of didanosine are increased, which may increase didanosine-associated toxicity [ see  Clinical Pharmacology (12.3)   Ribavirin- exposures of the active metabolite of didanosine (dideoxyadenosine 5'-triphosphate) are increased. Fatal hepatic failure, as well as peripheral neuropathy, pancreatitis, and symptomatic hyperlactatemia/lactic acidosis have been reported in patients receiving both didanosine and ribavirin.\""
    } ],
    "https://w3id.org/biolink/vocab/provided_by" : [ {
      "@id" : "https://w3id.org/um/NeuroDKG"
    } ],
    "https://w3id.org/biolink/vocab/relation" : [ {
      "@id" : "https://schema.org/MedicalContraindication"
    } ]
  }, {
    "@id" : "https://identifiers.org/drugbank:DB00900",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Drug"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#assertion",
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8",
    "http://purl.org/dc/terms/created" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2021-08-25T14:00:28.988+02:00"
    } ],
    "http://purl.org/dc/terms/creator" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ {
      "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ {
      "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ {
      "@id" : "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#sig",
    "http://purl.org/nanopub/x/hasAlgorithm" : [ {
      "@value" : "RSA"
    } ],
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "Z0p4ng4ay2tqerdaaoCmOrIr3hqPej9UFwlEJYUQGn85yaSJuI0TYa04j3Wdd7BPnPP+E9pP8wYHkqGdXoHroUA7bATCO+hKHcBsWlMnuvo4b6VZKp75q6aH/ARlXUqZRLFvcKgEh5Q0mOXa4Pg/j96+n+m4CNltTU/tmFASl1Y="
    } ],
    "http://purl.org/nanopub/x/hasSignatureTarget" : [ {
      "@id" : "http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#pubinfo"
} ]